Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BHV-1530 |
Synonyms | |
Therapy Description |
BHV-1530 (AMB302) is an antibody-drug conjugate (ADC) comprising an FGFR3 antibody linked to a topoisomerase I inhibitor with ligase-dependent conjugation, which potentially inhibits growth of tumors with FGFR fusions or overexpression (Cancer Res (2023) 83 (7_Supplement): 2634). |